Biote CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Marc D Beer, Executive Chairman and a Director of biote Corp., purchased 131,950 shares of common stock on August 10, 2026.
NASDAQ
Biote Corp. Interim CEO Robert Peterson was granted 206,746 stock options as part of his compensation package.
NASDAQ
Director Bret Christensen was granted 130,000 stock options in Biote Corp. with an exercise price of $2.34.
NASDAQ
Executive Chairman Marc D. Beer was granted 114,157 employee stock options in Biote Corp. with an exercise price of $2.34.
NASDAQ
Director Debra L. Morris reported the acquisition of Class A Common Stock and new equity awards in Biote Corp.
NASDAQ
Director Stephen Mark Cone was granted 31,481 deferred settlement RSUs and 130,000 stock options by Biote Corp.
NASDAQ
Director Dana Lynn Jacoby was granted 37,777 deferred settlement RSUs and 130,000 stock options by Biote Corp.
NASDAQ
Director Marc D. Beer was granted 195,000 stock options in Biote Corp. with an exercise price of $2.20.
NASDAQ
Director Richard R. Barrera was granted 121,452 stock options in Biote Corp. with an exercise price of $2.20.
NASDAQ
Biote Corp. reports that General Counsel Daniel Michael Monico was granted 88,800 employee stock options with an exercise price of $2.19.
NASDAQ
Biote Corp. CEO Bret Christensen has acquired stock options, with a portion vesting in April 2027 and the remainder over the following 36 months.
NASDAQ
Biote Corp. Chief Financial Officer Robert Peterson has been granted a stock option for 107,169 shares with an exercise price of $1.43, vesting over time starting April 1, 2027.
NASDAQ
Richard R. Barrera, a Director and 10% Owner of biote Corp., was granted 150,439 stock options with an exercise price of $3.93, vesting monthly over three years starting July 9, 2025.
NASDAQ
Director Debra L. Morris reports acquisition and disposal of Biote Corp. Class A Common Stock and Restricted Stock Units (RSUs).
NASDAQ
Director Steven J. Heyer acquired stock options for 104,547 shares of Biote Corp. on May 13, 2025.
NASDAQ
Director Dana Lynn Jacoby reports acquisition and disposal of Biote Corp. Class A Common Stock and Deferred Settlement RSUs.
NASDAQ
Director Andrew R. Heyer reports acquisition of stock options and restricted stock units (RSUs) in Biote Corp.
NASDAQ
Director Stephen Mark Cone reports acquisition of stock options and restricted stock units (RSUs) in Biote Corp.
NASDAQ
Guines LLC, along with related entities and individuals, increased its holdings in biote Corp. through a series of open market purchases of Class A common stock.
NASDAQ
Guines LLC, along with related entities and individuals, reports the acquisition of 1,933 shares of biote Corp. Class A common stock at a weighted average price of $3.296 per share.
NASDAQ
Guines LLC, along with related entities and individuals, reported the acquisition of additional shares of biote Corp. (BTMD) common stock at an average price of $3.2703 per share.
NASDAQ
Guines LLC, along with related entities and individuals, reported purchasing additional shares of biote Corp. (BTMD) common stock in open market transactions.
NASDAQ
Guines LLC, along with related entities and individuals, has increased its holdings in biote Corp. (BTMD) through a series of open market purchases of Class A common stock.
NASDAQ
Guines LLC, along with related entities and individuals, has increased its holdings in biote Corp. through a series of open market purchases of Class A common stock.
NASDAQ
Guines LLC, along with related entities and individuals, has increased its holdings in biote Corp. through a series of stock purchases in March 2025.
NASDAQ
Guines LLC, along with related entities and individuals, reports the acquisition of 106,000 shares of biote Corp. at $3.32 per share, increasing their total holdings to 4,033,547 shares.
NASDAQ
Executive Chairman of Biote Corp., Marc D. Beer, was granted stock options for 495,600 shares of Class A Common Stock on April 1, 2025, according to a Form 4 filing.
NASDAQ
Robert Charles Peterson, CFO of Biote Corp., received stock options for 350,000 shares of Class A Common Stock on April 1, 2025.
NASDAQ
Mary Elizabeth Conlon, General Counsel of Biote Corp., reports acquisition of stock options.
NASDAQ
Andrew R. Heyer, a director of Biote Corp., has increased his beneficial ownership through recent purchases of Class A Common Stock.